NPX
DEAD

Serial Number

98243882

Owner

Solvemed Group sp. z o.o.

Attorney

John Paul Oleksiuk

Filing Date

Oct 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NPX Trademark

Serial Number: 98243882

NPX is a trademark filed by Solvemed Group sp. z o.o. on October 27, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Solvemed Group sp. z o.o. (5 trademarks)

Ul. Swiety Marcin 29/8
Poznan 61-806 , PL

Entity Type: 99

Trademark Details

Filing Date

October 27, 2023

Registration Date

Not Registered

Goods & Services

Biometric software for pupillometry and eye tracking measurement; Software as a medical device (SaMD), downloadable, for the diagnosis of balance disorders by recording, viewing, or analyzing pupillometry and eye movements tracking; Downloadable computer software for controlling and managing patient medical information; Pupillometry software; Medical devices, namely, pupilometers; Downloadable computer software using machine learning software for healthcare purposes; Downloadable computer software for medical apparatus used in pupillometry; Downloadable computer software for monitoring pupillometry biomarkers; Downloadable computer software for monitoring of neurological and neurodegenerative diseases; Computer hardware and downloadable software for pupillometry and collecting eye-tracking data; Computer hardware and software for analyzing and reporting pupillometry and eye-tracking data for the purposes of assessing individuals' performance, for making recommendations to improve individuals' performance, and for predictive modeling and analytics, for use in scientific research, and for use in marketing

Medical services; Medical analysis services relating to the treatment and diagnosis of persons; Remote monitoring of medical data for medical diagnosis and treatment; Medical screening in the following fields: Diagnosis and treatment of neurological and neurodegenerative diseases; Medical services relating to pupillometry; Monitoring of patient condition using pupillometers; Medical services relating to disease progression by non-invasive methods; Medical services, in the fields of Ophthalmology, Optics and Optometric services; Medical diagnostic services relating to the use of pupillometry biomarkers

Laboratory Research in the field of pupillometry and eye tracking; Technological research in the field of pupillometry and eye tracking; Research relating to the development of new products and medical services; Design, engineering, research, development and testing service in the field of pupillometry and eye tracking for medical, scientific, and technological applications; Scientific and technological healthcare monitoring services including neurological status of patient, namely, in the field of pupillometry and eye tracking; Research and development services in connection with pupillometry and eye tracking; Medical research; Design and development of medical diagnostic apparatus; Scientific and medical research relating to the diagnosis and treatment of neurological and neurodegenerative diseases; Scientific and medical research relating to the development of non-invasive diagnostic methods based on pupillometry; Scientific and medical research, in the fields of Ophthalmology, Optics and Optometry; Scientific and medical research relating to searching of new biomarkers

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 16, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2025 COAR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 17, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 17, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2024 CNRT
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2023 NWOS
NEW APPLICATION ENTERED
Oct 31, 2023 NWAP